the aid library - It's Over 9000!

LIST OPTIONS

Filter

3717

Download (399)

View PDF (761)

Selected Practice Recommendations for Contraceptive Use

Erin Berry-Bibee, Melissa Chen, Kathryn Curtis et al. World Health Organization (WHO) (2016) C_WHO

Download (341)

View PDF (490)

The Kenya Urban Reproductive Health Initiative (Tupange) Endline Findings for Machakos

Kenya National Bureau of Statistics, MLE Initiative (2015) C1

Download (625)

View PDF (778)

Kangaroo Mother Care & Optimal Feeding of Low Birth Weight Infants

Child Health Division, Ministry of Health and Social Welfare, Government of India (2014) C1

Operational Guidelines for Programme Managers & Service Providers

Download (260)

View PDF (666)

Condom Promotion by State AIDS Control Societies - Operational Guidelines

National AIDSControl (NACO), Government of India; Ministry of Health and Family Welfare (2015) C1

Download (108)

View PDF (182)

Lehre am Puls der Zeit. Global Health in der medizinischen Ausbildung

Bundesvertretung der Medizinstudierenden in Deutschland BVMD; Globalisation and Health Initiative (GandHI). (2009) CC

Positionen, Lernziele und methodische Empfehlungen. Mit diesem Dokument soll die Diskussion um mögliche Konzepte zur Erweiterung der medizinischen Ausbildung um das disziplinübergreifende Fachgebiet Global Health anzuregen, bestehende fachliche Ressourcen unter diesem Dach zu vereinen und von stu... more

Download (864)

View PDF (1323)

Malawi National Guidelines for Kangaroo Mother Care

Ministry of Health, Malawi (2009) C1

Guidelines

Download (650)

View PDF (2598)

How to Investigate Antimicrobial Use in Hospitals: Selected Indicators

USAID; Strengthening Pharmaceutical Systems (2008) C1

The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T... more

Download (156)

View PDF (262)

Rwanda: FAMILY PLANNING STRATEGIC PLAN 2012–2016

Ministry of Health, Rwanda (2012) C2

In recent years, Rwanda has been on the fast track to achieve major health improvements for its entire population. With the support of government agencies and various non-governmental partners, the Ministry of Health (MoH) has endeavored to decentralize Rwanda’s health system and bring health serv... more

Download (61)

View PDF (90)

Determinants Of Coital Frequency Among Married Women In Central African Republic: The Role Of Female Genital Cutting

Stewart H.; L. Morrison; R. White Journal of Biosocial Science (2002) C1

Journal of Biosocial Science / Volume 34 / Issue 04 / October 2002, pp 525 - 539 DOI: DOI:10.1017/S0021932002005254, Published online: 24 September 2002 This paper examines determinants of one aspect of sexual behaviour – coital frequency – among 2188 married women in the Central African Re... more

Download (54)

View PDF (84)

Interim Guidance: Gender Alert for COVID-19 Outbreak

Inter-Agency Standing Committee IASC, et al. (2020) C1

Recognizing the extent to which the COVID-19 outbreaks affects women and men differently is hugely important. Some preliminary data suggested that more men than women are dying, potentially due to sex-based immunological differences, higher rates of cardiovascular disease for men and lifestyle choic... more

Download (31)

View PDF (864)

Ecosystem services and agriculture: tradeoffs and synergies

The Royal Society Publishing (2010) C2

Phil. Trans. R. Soc. B (2010) 365, 2959–2971; doi:10.1098/rstb.2010.0143. Agricultural ecosystems provide humans with food, forage, bioenergy and pharmaceuticals and are essential to human wellbeing. These systems rely on ecosystem services provided by natural ecosystems, including pollination, b... more

Download (64)

View PDF (139)

Influencing food environments for healthy diets

Food and Agriculture Organization of the United Nations FAO (2016) C2

Food environments are usually defined as the settings with all the different types of food made available and accessible to people as they go about their daily lives. That is, the range of food in supermarkets, small retail outlets, wet markets, street food stalls, coffee shops, tea houses, s...chool canteens, restaurants, and all the other venues where people buy and eat food. These environments differ enormously depending on the context. They can be extensive and diverse, with a seemingly endless array of options and price ranges, or they can be sparse, with very few options on offer. Because they determine what food consumers can access at a given moment in time, at what price, and with what degree of convenience, food environments both constrain and prompt the consumer’s choice.Food environments are influenced by the food systems which supply them, and vice versa. Food systems encompass the entire range of activities, people and institutions involved in the production, processing, marketing, consumption and disposal of food (FAO, 2013). They include but are not limited to food supply chains. Making food systems nutrition-sensitive can contribute to addressing all forms of malnutrition, as food systems determine whether the food needed for good nutrition are available, affordable, acceptable and of adequate quantity and quality. How closely food systems and food environments are interrelated and interdependent, and the degree to which external factors affect nutrition outcomes, varies from setting to setting.Many of today’s food systems and food environments are challenged in supporting consumer choices that are consistent with healthy diets and good nutrition. Consumers are not making choices based on nutrition and health, and poor diet is now the number one risk factor for death and disability worldwide (GBD, 2015). Food systems that do not enable healthy diets are increasingly recognized as an underlying cause of malnutrition (GLOPAN, 2016), and malnutrition, irrespective of form, has a huge cost. Economic costs associated with undernutrition are estimated at $1-2 trillion per year, about 2-3% of global GDP (FAO, 2013); the global economic cost of obesity and associated diet-related non-communicable diseases is estimated at $2 trillion per year, about 2.8% of global GDP (McKinsey, 2014). Influencing food environments for promoting healthy diets is an emerging strategy to address today’s nutrition challenges. more

Download (824)

View PDF (143)

Primary Surgery Vol. One: Non-Trauma
recommended

Cotton, M., et al. Global Healp; Deutsche Gesellschaft für Tropenchirurgie; International Coll. Essential Surgery (2016) CC

This comprehensive book has established itself as the most useful text for the medical practitioner in poor-resource settings who is obliged to manage surgical cases. It is particularly adapted for those whose surgical experience is basic or minimal. Importantly, it has extensive advice about pitfal... more

Download (31)

View PDF (491)

Impact of climate change on global malaria distribution

Cyril Caminade, Sari Kovats, Joacim Rocklov et al. PNAS (2014) CC

PNAS | March 4, 2014 | vol. 111 | no. 9 Malaria is an important disease that has a global distribution and significant health burden. The spatial limits of its distribution and seasonal activity are sensitive to climate factors, as well as the local capacity to control the disease. Malaria is also ... more

Download (61)

View PDF (95)

Female Genital Mutilation (FGM)

International Plannes Parenthood Foundation IPPF (2008) CC

Briefing Paper

Download (144)

View PDF (277)

Policies to protect children from the harmful impact of food marketing: WHO guideline

World Health Organisation (WHO) (2023) C_WHO

Children continue to be exposed to powerful food marketing, which predominantly promotes foods high in saturated fatty acids, trans-fatty acids, free sugars and/or sodium and uses a wide variety of marketing strategies that are likely to appeal to children. Food marketing has a harmful impact on chi... more

Download (71)

View PDF (66)

From Double Shock to Double Recovery – Implications and Options for Health Financing in the Time of COVID-19

Kurowski, C.; D. B. Evans; A. Tandon et al. The World Bank (2021) CC

The COVID-19 pandemic has resulted in a double shock - health and economic. As of March 1, 2021, COVID-19 has cost more than 2.5 million lives and triggered an economic recession surpassing any economic downturn since World War II. Part I of this paper explores the impact of this current macro-fisc... more

Download (48)

View PDF (228)

The path that ends AIDS: UNAIDS Global AIDS Update 2023
recommended

UN Children's Fund UNICEF (2023) CC

This report makes clear that there is a path to end AIDS. Taking that path will help ensure preparedness to address other pandemic challenges, and advance progress across the Sustainable Development Goals. The data and real-world examples in the report make it very clear what that path is. It is not... more

Download (128)

View PDF (96)

Global Accelerated Action for the Health of Adolescents (AA-HA!): guidance to support country implementation, second edition.

World Health Organization WHO (2023) C_WHO

The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents. The guidance pro... more

Download (163)

View PDF (206)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Primary Surgery Vol. One: Non-Trauma recommended

The path that ends AIDS: UNAIDS Global AIDS Update 2023 recommended

Primary Surgery Vol. One: Non-Trauma
recommended

The path that ends AIDS: UNAIDS Global AIDS Update 2023
recommended